Publications by authors named "Matteo Incerti"

Claim this Profile
H
HIV nucleocapsid proteins as targets for novel 1,2-benzisothiazol-3(2H)-one benzenesulfonamides: synthesis and antiretroviral activity.
Roberta Loddo, Matteo Incerti, Elda Favari, Valeria Manca, Marta Cogoni

Front Microbiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia.
Anouar Hafiane, Annalisa Ronca, Matteo Incerti, Alessandra Rossi, Matteo Manfredini

Eur J Med Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleoside Derivatives of 2,6-Diaminopurine Antivirals: Base-Modified Nucleosides with Broad-Spectrum Antimicrobial Properties.
Maria Grazia Martina, Federica Giammarino, Ilaria Vicenti, Elisabetta Groaz, Jef Rozenski, Matteo Incerti

ChemMedChem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis.
Marika Allodi, Carmine Giorgio, Matteo Incerti, Domenico Corradi, Lisa Flammini

Eur J Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: Results from the CARDIVEG study.
Annalisa Ronca, Nicoletta Pellegrini, Giuditta Pagliai, Monica Dinu, Matteo Manfredini, Matteo Incerti

Nutr Metab Cardiovasc Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC.
Maria Pia Adorni, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.
Maria Grazia Martina, Ilaria Vicenti, Lisa Bauer, Emmanuele Crespan, Enrico Rango, Matteo Incerti

ChemMedChem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice.
Francesca Ferlenghi, Carmine Giorgio, Matteo Incerti, Lorenzo Guidetti, Paola Chiodelli

Pharmaceuticals (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages.
Anouar Hafiane, Alessandro Pisaturo, Annalisa Ronca, Matteo Incerti, Robert S Kiss

BBA Adv· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC /J Mice.
Miriam Corrado, Carmine Giorgio, Elisabetta Barocelli, Giuseppe Vittucci Marzetti, Anna Maria Cantoni, Matteo Incerti

Pharmaceuticals (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.
Matteo Incerti, Simonetta Russo, Miriam Corrado, Carmine Giorgio, Vigilio Ballabeni

Eur J Med Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies.
Matteo Incerti, Lucia Crascì, Paola Vicini, Esin Aki, Ismail Yalcin

Molecules· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.
Carmine Giorgio, Matteo Incerti, Miriam Corrado, Marco Rusnati, Paola Chiodelli

Biochem Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Eph/ephrin system in cancer therapy.
Alessio Lodola, Carmine Giorgio, Matteo Incerti, Ilaria Zanotti, Massimiliano Tognolini

Eur J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New -(2-phenyl-4-oxo-1,3-thiazolidin-3-yl)-1,2-benzothiazole-3-carboxamides and acetamides as antimicrobial agents.
Matteo Incerti, Paola Vicini, Athina Geronikaki, Phaedra Eleftheriou, Athanasios Tsagkadouras

Medchemcomm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.
Matteo Incerti, Simonetta Russo, Donatella Callegari, Daniele Pala, Carmine Giorgio

J Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return.
Simonetta Russo, Donatella Callegari, Matteo Incerti, Daniele Pala, Carmine Giorgio

Chemistry· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis.
Carmine Giorgio, Simonetta Russo, Matteo Incerti, Antonella Bugatti, Federica Vacondio

Biochem Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.
Riccardo Castelli, Massimiliano Tognolini, Federica Vacondio, Matteo Incerti, Daniele Pala

Eur J Med Chem· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists.
Donatella Callegari, Daniele Pala, Laura Scalvini, Massimiliano Tognolini, Matteo Incerti

Molecules· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.
Lucia Crascì, Paola Vicini, Matteo Incerti, Venera Cardile, Sergio Avondo

Bioorg Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we using the right pharmacological tools to target EphA4?
Massimiliano Tognolini, Matteo Incerti, Alessio Lodola

ACS Chem Neurosci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents.
Salah A Al-Trawneh, Mustafa M El-Abadelah, Mohammad M Al-Abadleh, Franca Zani, Matteo Incerti

Eur J Med Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists.
Alessio Lodola, Matteo Incerti, Massimiliano Tognolini

J Virol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction.
Daniele Pala, Riccardo Castelli, Matteo Incerti, Simonetta Russo, Massimiliano Tognolini

J Chem Inf Model· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis